Evidence-Based Benefits
- IBS symptom reduction — a 2018 meta-analysis by Ford et al. in the American Journal of Gastroenterology analyzing 53 RCTs (n=5,545) found probiotics significantly reduced global IBS symptoms, abdominal pain, and bloating compared to placebo, with multi-strain formulations showing the strongest effects
- Antibiotic-associated diarrhea prevention — a 2015 Cochrane review by Hao et al. analyzing 13 RCTs found probiotics (particularly Lactobacillus and Saccharomyces boulardii) reduced the incidence of antibiotic-associated upper respiratory infections and supported immune function during antibiotic treatment
- Immune modulation — probiotics interact with gut-associated lymphoid tissue (GALT), which houses ~70% of the immune system, modulating both innate and adaptive immune responses through toll-like receptor signaling and cytokine regulation
- Gut-brain axis support — the vagus nerve connects the gut microbiome to the central nervous system; a 2019 systematic review found specific probiotic strains (L. rhamnosus, B. longum) reduced anxiety and depressive symptoms through GABA modulation and inflammatory cytokine reduction
- Microbiome diversity — probiotic supplementation can increase alpha diversity and support the growth of commensal bacteria, creating a more resilient gut ecosystem that resists pathogenic colonization